Healthcare data analytics startup Clearsense raised $50 million in a Series D funding round led by HealthQuest Capital, with participation from Health Catalyst Capital and UPMC Enterprises.
Along with the funding, Anthony Williams, partner at HealthQuest, will join Clearsense’s board. The startup raised $30 million in funding in 2021.
“This investment into our organization further strengthens our mission to unlock the full potential of healthcare data by delivering solutions that empower data confidence and enable data-driven decision-making to achieve better outcomes,” Gene Scheurer, CEO of Clearsense, said in a statement. “We’re elated to begin a relationship with HealthQuest, which shares the same vision: Transforming healthcare.”
Respiratory health startup Aluna scored $15.3 million in a Series B round led by previous investor Matrix Partners.
Other participants in the raise include Rho Ignition and allergist Dr. Warner Carr. The company said the funding brings its total funding to $27 million.
Aluna offers a connected spirometer and app for patients with respiratory conditions like asthma, cystic fibrosis and COPD. Users can collect information about their symptoms, medication use, activity and environment, and then transmit data to their providers.
“As two of many asthma sufferers, my cofounder and I set out from day one to build a platform that would not only keep patients healthy, but also help providers provide the best possible care,” CEO Charvi Shetty said in a statement. “Our growth will enable asthma, COPD and other chronic respiratory patients and their providers to work more effectively together and prevent attacks before they happen. Down the road, we hope to leverage our lung health data to revolutionize respiratory care.”
AnswersNow, which provides virtual applied behavior analysis therapy for children with autism and other developmental conditions, announced Thursday it had raised $11 million in Series A financing.
The round was led by Left Lane Capital, with participation from the American Family Institute for Social Impact, Blue Heron Capital, Difference Partners and Lani Fritts, the former CEO of ABA provider Kadiant.
The company will use the capital to expand into new states, hire more clinicians and improve the user experience of its platform.
“This latest round of funding enables us to impact the lives of more families, many of whom have been sitting on waitlists for months, or who live in areas where there’s not even one board certified clinician. With no waitlist and a robust team of PhD and Master’s-level clinicians on-hand, we can quickly connect families to individualized, effective therapy from the safety and comfort of their homes,” Jeff Beck, AnswersNow CEO and cofounder, said in a statement.
Teal Health, which is developing an at-home cervical cancer screening, announced it had raised $8.8 million in seed funding from Emerson Collective, Serena Ventures, Metrodora Ventures and Felicis Ventures.
The startup said the seed will go toward product development, clinical studies and submission to the FDA.
“For far too long women have been disenfranchised by their current healthcare experiences, with women of underrepresented communities feeling an increased strain on their access and options surrounding healthcare. We’re excited to partner with Teal to increase equity and access to this life-saving screening by removing the barriers such as awareness, time, and fear; while also empowering women to reconnect and take control of their health,” Serena Williams, managing partner at Serena Ventures, said in a statement.
Levels, which touts a platform that uses continuous glucose monitoring data to provide insights on how diet and activity affect metabolic health, raised a $7 million extension to its Series A round.
The startup announced it had scooped up $38 million in April. Investors include TriplePoint Capital, Andreessen Horowitz, Trust Ventures and Shrug Capital.